Open Access

Spectrum of MAP3K1 mutations in breast cancer is luminal subtype‑predominant and related to prognosis

  • Authors:
    • Cheukfai Li
    • Guochun Zhang
    • Yulei Wang
    • Bo Chen
    • Kai Li
    • Li Cao
    • Chongyang Ren
    • Lingzhu Wen
    • Minghan Jia
    • Hsiaopei Mok
    • Jianguo Lai
    • Weikai Xiao
    • Xuerui Li
    • Ning Liao
  • View Affiliations

  • Published online on: January 3, 2022     https://doi.org/10.3892/ol.2022.13187
  • Article Number: 68
  • Copyright: © Li et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

MAP3K1 is a MAPK family serine‑threonine kinase that is frequently mutated in human cancer. The association between mutations in the MAP3K1 gene and the clinicopathological characteristics and prognosis of patients with breast cancer remain unclear in the Chinese population. Thus, the aim of the present retrospective study was to investigate the possible role and function of MAP3K1 in breast cancer. Data obtained from 412 consecutive patients with breast cancer were selected from Guangdong Provincial People's Hospital (GDPH) for analysis in the present study. Mutations were assessed using next‑generation sequencing. The association between MAP3K1 mutations and clinicopathological features were analyzed and further compared with the Molecular Taxonomy of Breast Cancer International Consortium (METABRIC) cohort and data from The Cancer Genome Atlas (TCGA). In the GDPH cohort, a total of 45 mutations MAP3K1 were identified in 8.5% (n=35) of the 412 patients, compared with 9.7% (n=244) in METABRIC and 7.9% (n=88) in TCGA. The majority of the mutations identified in the in three cohorts were truncating mutations, followed by mis‑sense mutations. Mutations in MAP3K1 were predominant in patients with the luminal A and B breast cancer subtypes in METABRIC datasets (P<0.001), although no significant differences were observed in the GDPH cohort (P=0.227). In the METABRIC cohort, patients with MAP3K1 mutations experienced a improved overall survival (OS) rate than patients without MAP3K1 mutations (P=0.006). In patient with hormone receptor (HR)+ breast cancer, a more significantly higher OS rate was observed in patients with MAP3K1 mutations (P<0.001). MAP3K1 expression was associated with OS in the HR+ subgroup. Moreover, the MAP3K1 methylation levels were reduced in primary breast cancer tissue, compared with normal tissue. Thus, the present findings identified MAP3K1 mutations in Chinese patients with breast cancer, and compared MAP3K1 mutations between the cohorts from Western and Eastern countries.
View Figures
View References

Related Articles

Journal Cover

February-2022
Volume 23 Issue 2

Print ISSN: 1792-1074
Online ISSN:1792-1082

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Li C, Zhang G, Wang Y, Chen B, Li K, Cao L, Ren C, Wen L, Jia M, Mok H, Mok H, et al: Spectrum of <em>MAP3K1</em> mutations in breast cancer is luminal subtype‑predominant and related to prognosis. Oncol Lett 23: 68, 2022
APA
Li, C., Zhang, G., Wang, Y., Chen, B., Li, K., Cao, L. ... Liao, N. (2022). Spectrum of <em>MAP3K1</em> mutations in breast cancer is luminal subtype‑predominant and related to prognosis. Oncology Letters, 23, 68. https://doi.org/10.3892/ol.2022.13187
MLA
Li, C., Zhang, G., Wang, Y., Chen, B., Li, K., Cao, L., Ren, C., Wen, L., Jia, M., Mok, H., Lai, J., Xiao, W., Li, X., Liao, N."Spectrum of <em>MAP3K1</em> mutations in breast cancer is luminal subtype‑predominant and related to prognosis". Oncology Letters 23.2 (2022): 68.
Chicago
Li, C., Zhang, G., Wang, Y., Chen, B., Li, K., Cao, L., Ren, C., Wen, L., Jia, M., Mok, H., Lai, J., Xiao, W., Li, X., Liao, N."Spectrum of <em>MAP3K1</em> mutations in breast cancer is luminal subtype‑predominant and related to prognosis". Oncology Letters 23, no. 2 (2022): 68. https://doi.org/10.3892/ol.2022.13187